Stay updated with breaking news from Jiang Gao. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A group of researchers in Egypt have lost a second paper on possible treatments for COVID-19 after questions were raised about the legitimacy of their trial findings.
Rapid Antibody Testing For COVID-19 by Pooja Shete on January 11, 2021 at 12:43 PM An advanced nanomaterial-based biosensing platform has been found by the researchers that detects antibodies specific to SARS-CoV-2, the virus responsible for the COVID-19 pandemic within seconds. Additional to testing, this platform will help to quantify patient immunological response to the new vaccines with precision. The study conducted by researchers at Carnegie Mellon University in collaboration with University of Pittsburgh (Pitt) and the UPMC is published in the journal Advanced Mat...
Indian-Origin scientist develops nano 3D device to detect Covid-19 virus in 15 seconds Posted by: Narsingrao Sridhar January 10, 2021 Researchers at Carnegie Mellon University have developed an advanced nanomaterial-based biosensing platform that detects, within seconds, antibodies specific to SARS-CoV-2 or the coronavirus. It also helps to assess patient immunological response to the new vaccine. The study, published in the journal Advanced Materials, is Carnegie Mellon’s collaboration with the University of Pittsburgh (Pitt) and the UPMC. The testing platform identifies the presenc...
E-Mail IMAGE: An image of the COVID-19 test chip made by aerosol jet nanoparticle 3D printing. view more Credit: Advanced Manufacturing and Materials Lab, College of Engineering, Carnegie Mellon University PITTSBURGH--Researchers at Carnegie Mellon University report findings on an advanced nanomaterial-based biosensing platform that detects, within seconds, antibodies specific to SARS-CoV-2, the virus responsible for the COVID-19 pandemic. In addition to testing, the platform will help to quantify patient immunological response to the new vaccines with precision. The results were...
Advanced Manufacturing and Materials Lab, College of Engineering, Carnegie Mellon University PITTSBURGH -- Researchers at Carnegie Mellon University report findings on an advanced nanomaterial-based biosensing platform that detects, within seconds, antibodies specific to SARS-CoV-2, the virus responsible for the COVID-19 pandemic. In addition to testing, the platform will help to quantify patient immunological response to the new vaccines with precision. The results were published this week in the journal Advanced Materials. Carnegie Mellon's collaborators included the University of Pittsbu...